These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6947720)

  • 21. Tissue distribution of poly(hexyl 2-cyanoacrylate) nanoparticles coated with monoclonal antibodies in mice bearing human tumor xenografts.
    Illum L; Jones PD; Baldwin RW; Davis SS
    J Pharmacol Exp Ther; 1984 Sep; 230(3):733-6. PubMed ID: 6590835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening human antibody libraries against carcinoma cells by affinity purification and polymerase chain reaction.
    Reiersen H; Berntsen G; Stassar M; Cochlovius B
    J Immunol Methods; 2008 Jan; 330(1-2):44-56. PubMed ID: 18082761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A human-mouse chimeric Lym-1 monoclonal antibody with specificity for human lymphomas expressed in a baculovirus system.
    Hu P; Glasky MS; Yun A; Alauddin MM; Hornick JL; Khawli LA; Epstein AL
    Hum Antibodies Hybridomas; 1995; 6(2):57-67. PubMed ID: 7492752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural IgM antibodies and immunosurveillance mechanisms against epithelial cancer cells in humans.
    Brändlein S; Pohle T; Ruoff N; Wozniak E; Müller-Hermelink HK; Vollmers HP
    Cancer Res; 2003 Nov; 63(22):7995-8005. PubMed ID: 14633732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytotoxic properties of an immunotoxin interacting with mouse myeloma cells].
    Tonevitskiĭ AG; Trakht IN
    Dokl Akad Nauk SSSR; 1984; 277(3):756-9. PubMed ID: 6386405
    [No Abstract]   [Full Text] [Related]  

  • 26. Pilot scale purification of human monoclonal IgM (COU-1) for clinical trials.
    Tornøe I; Titlestad IL; Kejling K; Erb K; Ditzel HJ; Jensenius JC
    J Immunol Methods; 1997 Jun; 205(1):11-7. PubMed ID: 9236910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineered anti-CD38 monoclonal antibodies for immunotherapy of multiple myeloma.
    Ellis JH; Barber KA; Tutt A; Hale C; Lewis AP; Glennie MJ; Stevenson GT; Crowe JS
    J Immunol; 1995 Jul; 155(2):925-37. PubMed ID: 7608568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic natural antibodies against human tumours: an option for anti-cancer immunotherapy?
    Schwartz-Albiez R; Laban S; Eichmüller S; Kirschfink M
    Autoimmun Rev; 2008 Jun; 7(6):491-5. PubMed ID: 18558368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The isolation and characteristics of monoclonal antibodies to Mycobacterium smegmatis and M. kansasii].
    Kulikovskaia NV; Kapina MA; Kalinina OA; Chernousova LN
    Probl Tuberk; 1996; (1):43-6. PubMed ID: 8907487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystallization of intact monoclonal antibodies.
    Harris LJ; Skaletsky E; McPherson A
    Proteins; 1995 Oct; 23(2):285-9. PubMed ID: 8592710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibodies to rat sarcomata. I. Immunization procedures and source of lymphoid cells for hybridoma production.
    North SM; Styles JM; Hobbs SM; Dean CJ
    Immunology; 1982 Nov; 47(3):397-405. PubMed ID: 7129525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of serum antibodies induced in syngeneic rats after administration of monoclonal antibody MT10:21.
    North SM; Gurin JL
    Immunology; 1989 Jan; 66(1):26-31. PubMed ID: 15493258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and characterization of recombinant human anti-HAV monoclonal antibody.
    Wei JS; Tao R; Sun WW; Jia Q; Li C; Liang MF
    Sheng Wu Gong Cheng Xue Bao; 2004 Mar; 20(2):257-61. PubMed ID: 15969118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localization of anti-osteogenic sarcoma monoclonal antibody 791T/36 in a primary human osteogenic sarcoma and its subsequent xenograft in immunodeprived mice.
    Pimm MV; Perkins AC; Armitage NC; Baldwin RW
    Cancer Immunol Immunother; 1985; 19(1):18-21. PubMed ID: 3856475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibodies to apolipoprotein AI: generation and characterization.
    Falero G; Rodriguez I; Rojas A
    Folia Biol (Praha); 1993; 39(1):14-22. PubMed ID: 7688698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating antibodies in human connective tissue malignancy.
    Moore M; Hughes LA
    Br J Cancer Suppl; 1973 Aug; 1():175-84. PubMed ID: 4613373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33.
    Ritter G; Cohen LS; Williams C; Richards EC; Old LJ; Welt S
    Cancer Res; 2001 Sep; 61(18):6851-9. PubMed ID: 11559561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing the recovery of chemically reduced monoclonal antibody for site-specific technetium-99m radiolabeling.
    Boonkitticharoen V; James H; Cheung NK; Larson SM; Finn RD
    Biotechniques; 1993 May; 14(5):706-8. PubMed ID: 8512684
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of syngeneic (anti-idiotypic) antibody responses on biodistribution and tumour localisation of murine monoclonal antibodies and fragments.
    Pimm MV; Gribben SJ
    Anticancer Res; 1993; 13(1):241-8. PubMed ID: 8476219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour-bound immunoglobulins. The fate of immunoglobulin disappearing from the surface of coated tumour cells.
    Fish F; Witz IP; Klein G
    Clin Exp Immunol; 1974 Mar; 16(3):355-65. PubMed ID: 4549687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.